Close
Back to KNSA Stock Lookup
Pages: 1 2 3 4 »» Last Page

(KNSA) – Company Press Releases

Apr 16, 2024 04:01 PM Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024
Apr 2, 2024 07:30 AM Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart
Feb 28, 2024 07:30 AM Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution
Feb 21, 2024 04:01 PM Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
Jan 4, 2024 07:30 AM Kiniksa Pharmaceuticals Provides Corporate Update
Jan 2, 2024 04:01 PM Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference
Oct 31, 2023 07:30 AM Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution
Oct 24, 2023 04:01 PM Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023
Jul 25, 2023 07:30 AM Kiniksa Pharmaceuticals Reports Second Quarter 2023 Financial Results and Recent Portfolio Execution
Jul 17, 2023 08:00 AM Kiniksa Pharmaceuticals to Report Second Quarter 2023 Financial Results on July 25, 2023
Jun 6, 2023 04:01 PM Kiniksa Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference
May 2, 2023 07:30 AM Kiniksa Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Portfolio Execution
May 1, 2023 04:01 PM Kiniksa Pharmaceuticals to Report First Quarter 2023 Financial Results on May 2, 2023
Feb 28, 2023 08:00 AM Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Portfolio Execution
Feb 27, 2023 04:01 PM Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2022 Financial Results on February 28, 2023
Jan 9, 2023 08:00 AM Kiniksa Pharmaceuticals Provides Corporate and Portfolio Update
Jan 3, 2023 04:01 PM Kiniksa Pharmaceuticals to Present at 41st Annual J.P. Morgan Healthcare Conference
Nov 30, 2022 04:01 PM Kiniksa Pharmaceuticals to Present at Bank of America Securities 2022 Biotech SMID Cap Conference
Nov 23, 2022 04:01 PM Kiniksa Pharmaceuticals to Present at Evercore ISI 5th Annual HealthCONx Conference
Nov 1, 2022 08:00 AM Kiniksa Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Oct 31, 2022 04:01 PM Kiniksa Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 1, 2022
Sep 12, 2022 08:30 AM Kiniksa Pharmaceuticals Announces Closing of Global License Agreement with Genentech for Vixarelimab
Aug 3, 2022 04:01 PM Kiniksa Pharmaceuticals to Present at 2022 Wedbush PacGrow Healthcare Conference
Aug 3, 2022 07:30 AM Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Aug 3, 2022 07:29 AM Kiniksa Pharmaceuticals Announces Global License Agreement with Genentech for Vixarelimab
Aug 2, 2022 04:01 PM Kiniksa Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 3, 2022
May 3, 2022 08:00 AM Kiniksa Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 2, 2022 04:01 PM Kiniksa Pharmaceuticals to Report First Quarter 2022 Financial Results on May 3, 2022
Feb 22, 2022 08:00 AM Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
Feb 22, 2022 07:59 AM Kiniksa Pharmaceuticals and Huadong Medicine Announce Strategic Collaboration
Feb 18, 2022 04:01 PM Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2021 Financial Results on February 22, 2022
Jan 10, 2022 08:00 AM Kiniksa Provides Corporate Update and Outlines Anticipated 2022 Milestones
Jan 3, 2022 04:01 PM Kiniksa Pharmaceuticals to Present at 40th Annual J.P. Morgan Healthcare Conference
Dec 28, 2021 06:59 AM Kiniksa Announces Results from Phase 3 Trial of Mavrilimumab in COVID-19-Related ARDS
Nov 23, 2021 04:01 PM Kiniksa Pharmaceuticals to Present at Evercore ISI 4th Annual HealthCONx Conference
Nov 1, 2021 08:00 AM Kiniksa Pharmaceuticals Reports Third Quarter 2021 Financial Results and Recent Portfolio Execution
Oct 29, 2021 04:01 PM Kiniksa Pharmaceuticals to Report Third Quarter 2021 Financial Results on November 1, 2021
Sep 21, 2021 04:01 PM Kiniksa Pharmaceuticals to Present at 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
Aug 16, 2021 08:00 AM Kiniksa Announces Launch of ARCALYST Named Patient Program
Aug 3, 2021 08:00 AM Kiniksa Reports Second Quarter 2021 Financial Results and Recent Corporate and Portfolio Activity
Aug 2, 2021 04:01 PM Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference
Jul 20, 2021 04:01 PM Kiniksa Pharmaceuticals to Report Second Quarter 2021 Financial Results on August 3, 2021
Jun 8, 2021 04:01 PM Kiniksa Announces Issuance of U.S. Patent for Treatment of Recurrent Pericarditis
Jun 8, 2021 07:30 AM Kiniksa Outlines Next Steps for the Development of Mavrilimumab
Jun 1, 2021 04:01 PM Kiniksa Pharmaceuticals to Present at Goldman Sachs 42nd Annual Global Healthcare Conference
May 4, 2021 08:00 AM Kiniksa Reports First Quarter 2021 Financial Results and Recent Corporate and Portfolio Activity
May 4, 2021 07:59 AM Kiniksa Announces Positive Final Data from Phase 1 Trial of KPL-404
Apr 12, 2021 07:30 AM Kiniksa Announces Positive Results for Mavrilimumab Phase 2 Trial in Non-Mechanically Ventilated Severe COVID-19 Patients
Apr 1, 2021 08:00 AM Kiniksa Announces Commercial Availability of ARCALYST ® (rilonacept) for Recurrent Pericarditis
Mar 18, 2021 04:30 PM Kiniksa Announces FDA Approval of ARCALYST ® (rilonacept) for Recurrent Pericarditis
Pages: 1 2 3 4 »» Last Page

Back to KNSA Stock Lookup